Transcat FY2027 EPS Forecast Boosted by Northland Capmk

Transcat, Inc. (NASDAQ:TRNSFree Report) – Equities researchers at Northland Capmk upped their FY2027 earnings per share estimates for shares of Transcat in a research report issued on Wednesday, January 29th. Northland Capmk analyst E. Jackson now forecasts that the scientific and technical instruments company will earn $2.63 per share for the year, up from their prior estimate of $2.55. The consensus estimate for Transcat’s current full-year earnings is $2.39 per share. Northland Capmk also issued estimates for Transcat’s FY2028 earnings at $2.93 EPS and FY2029 earnings at $3.23 EPS.

A number of other research analysts have also recently weighed in on the stock. Northland Securities restated a “market perform” rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday. HC Wainwright cut their price objective on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research report on Wednesday. StockNews.com upgraded Transcat from a “sell” rating to a “hold” rating in a research note on Tuesday. Craig Hallum boosted their target price on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $111.50.

View Our Latest Stock Report on TRNS

Transcat Price Performance

Shares of NASDAQ:TRNS opened at $76.71 on Friday. The firm has a market capitalization of $705.73 million, a PE ratio of 41.46 and a beta of 0.71. Transcat has a 1 year low of $73.37 and a 1 year high of $147.12. The firm’s 50-day moving average is $103.79 and its two-hundred day moving average is $114.55.

Transcat (NASDAQ:TRNSGet Free Report) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.43% and a net margin of 6.22%. During the same period in the prior year, the firm posted $0.56 EPS.

Hedge Funds Weigh In On Transcat

Institutional investors and hedge funds have recently modified their holdings of the company. Essex Investment Management Co. LLC lifted its holdings in Transcat by 0.4% during the 3rd quarter. Essex Investment Management Co. LLC now owns 43,444 shares of the scientific and technical instruments company’s stock worth $5,247,000 after buying an additional 171 shares during the last quarter. US Bancorp DE raised its position in shares of Transcat by 15.6% during the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after acquiring an additional 209 shares in the last quarter. Ellsworth Advisors LLC raised its position in shares of Transcat by 4.4% during the 3rd quarter. Ellsworth Advisors LLC now owns 5,041 shares of the scientific and technical instruments company’s stock worth $609,000 after acquiring an additional 213 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Transcat by 8.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,312 shares of the scientific and technical instruments company’s stock worth $396,000 after purchasing an additional 263 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in Transcat by 8.8% in the third quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock valued at $557,000 after purchasing an additional 373 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.